Navigation Links
Study by Allegheny General Hospital Physicians Shows Oral Immunotherapy is a Safe, Effective Alternative to Allergy Shots for Ragweed Sufferers
Date:2/25/2013

II trial to demonstrate the clinical effectiveness of SLIT with liquid drops in treating ragweed allergy. The clinical improvement of 43 percent well exceeded the 20 percent that is the World Allergy Organization’s accepted norm for clinically meaningful improvement, Dr. Gentile said.

Dr. Gentile and AGH colleague David Skoner, MD, Director of AGH’s Division of Allergy, Asthma and Immunology, have been pioneers in the development of oral immunotherapy for allergy sufferers. Their studies have paved the way for this significant Phase III trial.

A study by the AGH Team that was published in 2010 by the Journal of Allergy and Clinical Immunology found that immunotherapy tablets taken by mouth were safe and effective in relieving Timothy grass allergy symptoms in children ages 5 to 17. Severity of symptoms improved by 26 percent in those who received the tablet vs. those who were randomly assigned to a placebo.

Another study, published in 2011 in the Journal of Allergy and Clinical Immunology found under-the-tongue tablets safe and effective for children and adolescents suffering from allergic rhinoconjunctivitis. And a 2012 study presented by Dr. Skoner at the annual meeting of the American Academy of Allergy, Asthma and Immunology found that under-the-tongue tablets were also effective and safe for adults suffering from allergic rhinoconjunctivitis.

At this year’s AAAAI conference, Dr. Skoner also presented the results of a nationwide survey showing that educational efforts are needed to improve patient expectations and knowledge about specific immunotherapy (SIT), which desensitizes patients to their allergens. It is one of the most effective therapies available for allergic rhinoconjunctivitis, which is one of the most common chronic diseases in the U.S.

A telephone survey of 2,765 people showed that only 32 percent had heard of SIT, and of those aware of it 65 percent had discussed it with their health care providers.

<
'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Doctors Health Press Reports on Study: Heart-Healthy Linoleic Acid Levels Decrease with Age
2. Columbus Center for Women’s Health Research is participating in an International Study for a New “Use-as-Needed” Treatment for Women with Sexual Dysfunction
3. UNC-led study documents head and neck cancer molecular tumor subtypes
4. Breast Reconstruction Using Womens Own Tissue Appears Safe: Study
5. Israel rocket attacks increase miscarriage likelihood -- Ben-Gurion U. research study
6. Plastics Chemical BPA Common in Preemie ICU: Study
7. Fitness Expert Lorna Kleidman Responds to Study Claiming Exercise Can Decrease Risk of Dementia
8. Dialysis Catheters Tied to Higher Risk for Infection, Death, Study Finds
9. Should grandma join Facebook? It may give her a cognitive boost, study finds
10. Climate Change Could Affect Monarch Butterflys Migration, Study Says
11. Blood Thinners May Boost Survival for Prostate Cancer Patients: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... ... ... SupplyLogic, a marketing execution partner based in metro New York and Chicago has ... Founder and CEO Kevin Sherlock discusses the value in supply chain visibility by quoting ... it the closer you get to the ocean, the more seafood costs?’ Those of ...
(Date:7/27/2015)... ... July 27, 2015 , ... Boston IVF, the first Massachusetts egg ... educational "Happy Hour" on Nantucket Island for women who wish to learn more ... Lady Restaurant and Bar, 2 Chins Way, Nantucket Island 02554 from 4:30-6:30pm. , This ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... ... serving communities in and around Dallas, Texas, is announcing a joint charity effort ... support and employment resources for American veterans who are returning from overseas. , ...
(Date:7/27/2015)... AL (PRWEB) , ... July 27, 2015 , ... Standifer ... announcing a charity drive that will support Camp Conquest, a specialized camp for young ... Alabama. , Camp Conquest offers a five day and four night curriculum designed to ...
(Date:7/27/2015)... ... 27, 2015 , ... Premier Insurance Advisors, a full service ... charity and awareness event with the Houston chapter of NAMI, the National Alliance ... to bettering the lives of the millions of Americans affected by mental illness. ...
Breaking Medicine News(10 mins):Health News:SupplyLogic Releases First Executive Blog on Supply Chain Management Issues 2Health News:Boston IVF to Host Egg Freezing Event in Nantucket on August 6th at 4:30pm 2Health News:Boston IVF to Host Egg Freezing Event in Nantucket on August 6th at 4:30pm 3Health News:The Tedesco Agency of North Dallas and Non-Profit IAVA Announce Joint Charity Effort to Support American Veterans 2Health News:Standifer Insurance Group and Camp Conquest Plan Joint Charity Initiative to Assist Hospitalized Children Suffering from Burn Injuries 2Health News:Standifer Insurance Group and Camp Conquest Plan Joint Charity Initiative to Assist Hospitalized Children Suffering from Burn Injuries 3Health News:Premier Insurance and the National Alliance of Mental Health Launch Grassroots Charity Effort to Support Houston Residents with Developmental Challenges 2Health News:Premier Insurance and the National Alliance of Mental Health Launch Grassroots Charity Effort to Support Houston Residents with Developmental Challenges 3
... (Nasdaq: KOOL ), a leading supplier of innovative ... that J. Melville Engle, the Company,s Chief Executive Officer, has ... the total number of directors to six. , , ... in the healthcare industry, joined the Company as Chief Executive ...
... Show That NUVIGIL Improves Excessive Sleepiness Associated with Jet ... Cephalon, Inc. (Nasdaq: CEPH ) presented ... Tablets [C-IV] significantly improved wakefulness in people with excessive ... three data were presented today at the SLEEP 2009 ...
... 26 Convictions, Forfeiture of Over $7 Million, and Sharing of Over $4 ... Rapids , and Des Moines ... Iowa, June 10 On March 24, 2003, a corner drugstore in ... an Internet prescription from a doctor in Mississippi. Six years and ...
... Researchers at The Wistar Institute have defined a key ... process of aging. The study, published June 11 in ... of aging that could point toward new anti-aging strategies ... that a class of proteins called sirtuins promotes fitness ...
... ... ... College of American Pathologists unveiled its Health Care Reform Agenda, citing key policy issues ... improve patient care in the future., , , , ,The College,s agenda addresses a ...
... all family members is warranted: report , WEDNESDAY, June ... children can suffer too. , A new report from ... calls for health and social service professionals to pay ... their children. , Rather than treating only the depressed ...
Cached Medicine News:Health News:ThermoGenesis Appoints Chief Executive Officer J. Melville ('Mel') Engle to Board of Directors 2Health News:ThermoGenesis Appoints Chief Executive Officer J. Melville ('Mel') Engle to Board of Directors 3Health News:ThermoGenesis Appoints Chief Executive Officer J. Melville ('Mel') Engle to Board of Directors 4Health News:NUVIGIL Jet Lag Disorder Data Presented at the SLEEP 2009 23rd Annual Meeting of the Associated Professional Sleep Societies 2Health News:NUVIGIL Jet Lag Disorder Data Presented at the SLEEP 2009 23rd Annual Meeting of the Associated Professional Sleep Societies 3Health News:NUVIGIL Jet Lag Disorder Data Presented at the SLEEP 2009 23rd Annual Meeting of the Associated Professional Sleep Societies 4Health News:NUVIGIL Jet Lag Disorder Data Presented at the SLEEP 2009 23rd Annual Meeting of the Associated Professional Sleep Societies 5Health News:Record-Breaking Internet Pharmacy Prosecution Nets Millions for Iowa Law Enforcement 2Health News:Record-Breaking Internet Pharmacy Prosecution Nets Millions for Iowa Law Enforcement 3Health News:Record-Breaking Internet Pharmacy Prosecution Nets Millions for Iowa Law Enforcement 4Health News:Record-Breaking Internet Pharmacy Prosecution Nets Millions for Iowa Law Enforcement 5Health News:Record-Breaking Internet Pharmacy Prosecution Nets Millions for Iowa Law Enforcement 6Health News:Record-Breaking Internet Pharmacy Prosecution Nets Millions for Iowa Law Enforcement 7Health News:Record-Breaking Internet Pharmacy Prosecution Nets Millions for Iowa Law Enforcement 8Health News:Wistar Institute team finds key target of aging regulator 2Health News:CAP Announces Health Care Reform Agenda 2Health News:CAP Announces Health Care Reform Agenda 3Health News:If Mom or Dad Is Depressed, Kids Need Help Too 2Health News:If Mom or Dad Is Depressed, Kids Need Help Too 3
(Date:7/27/2015)... and PITTSBURGH , July 27, 2015 ... it will hold its extraordinary general meeting of shareholders in ... PRGO ; TASE) at the Okura Hotel Amsterdam on ... (CET). Among other agenda items at the ... the approval, under article 2:107a of the Dutch Civil Code, ...
(Date:7/27/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/rq47bp/global_pressure ... Pressure Relief Devices Market 2015-2019" report to their ... to grow at a CAGR of 4.41% over the ... Market 2015-2019, has been prepared based on an in-depth ... covers the Americas, and the APAC and EMEA; it ...
(Date:7/27/2015)... PLEASANTON, Calif. , July 27, 2015  QT ... the "Group"), a global company engaged in the design, ... minimally invasive treatment of vascular disease, has entered into ... for up to US$13.14 million convertible bond investment. This ... help boost its growth to the next milestone. ...
Breaking Medicine Technology:Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 2Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 3Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 4Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 5Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 6Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 7Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 8Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 9Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 10Global Pressure Relief Devices Market 2015-2019 with ArjoHuntleigh, Hill-Rom, Paramount Bed Holdings & Stryker Dominating 2QT Vascular Obtains Funding To Boost Growth Through Issuance of up to US$13.14 Million Convertible Bonds 2QT Vascular Obtains Funding To Boost Growth Through Issuance of up to US$13.14 Million Convertible Bonds 3
... , SCOTTSDALE, Ariz. , Jan. 22 Matrixx Initiatives, ... financial results for the fiscal 2010 third quarter, ended December 31, ... January 25, 2010 . An earnings conference call will be held the ... AM ET . , To access the teleconference, please call (888) 452-4006 ...
... ... Called Ampyra, to Improve Walking for People With All Types of ... The U.S. Food and Drug Administration has approved the ... Therapeutics) for its ability to improve walking speed in people with ...
Cached Medicine Technology:Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2010 Financial Results 2Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 2Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 3Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 4Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 5Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 6
... For delivery of medication as well as ... refillable, closed dilution, high volume, continuous medication ... therapy to patients. Its 200 ml reservoir ... to 8 hours of nebulized medication delivery ...
Nebulizer Adapter Kit 6"...
... and Respiratory Products, ,Westmed designs, manufacturers ... Anesthesia and Respiratory professionals. Our mission is ... the clinician's ability to deliver quality medical ... bottom line. , ,Our web site ...
... and Respiratory Products, ,Westmed designs, manufacturers ... Anesthesia and Respiratory professionals. Our mission is ... the clinician's ability to deliver quality medical ... bottom line. , ,Our web site ...
Medicine Products: